Epstein Secrets

artment of Justice. EFTA00205055 Case 9:08-cv-80736-KAM Document 79-1 Entered on FLSD Docket 05/03/2011 Page 14 of 31 Page 2 of 4 6. While at the Public Integrity Section, I was involved in investigating and prosecuting people who violated federal conflict of interest and post- employment statutes. I attended multiple

nistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy tests on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as synopses of data from clinical trials, the communic

artment of Justice. EFTA00205086 Case 9:08-cv-80736-KAM Document 79-1 Entered on FLSD Docket 05/03/2011 Page 14 of 31 Page 2 of 4 6. While at the Public Integrity Section, I was involved in investigating and prosecuting people who violated federal conflict of interest and post- employment statutes. I attended multiple

nistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy tests on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as synopses of data from clinical trials, the communic

artment of Justice. EFTA00230049 Case 9:08-cv-80736-KAM Document 79-1 Entered on FLSD Dodket 05/03/2011 Page 14 of 31 Page 2 of 4 6. While at the Public Integrity Section, I was involved in investigating and prosecuting people who violated federal conflict of interest and post- employment statutes. I attended multiple

inistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy test on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as syncpses of data from clinical trials, the communic

36-CV-MARRA 000803 EFTA00230627 Case 9:08-cv-80736-KAM Document 79-1 Entered on FLSD Dodket 05/03/2011 Page 14 of 31 Page 2 of 4 6. While at the Public Integrity Section, I was involved in investigating and prosecuting people who violated federal conflict of interest and post- employment statutes. I attended multiple

inistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy test on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as syncpses of data from clinical trials, the communic